Compare OABI & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OABI | JFIN |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.8M | 330.9M |
| IPO Year | N/A | 2019 |
| Metric | OABI | JFIN |
|---|---|---|
| Price | $1.84 | $6.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 424.6K | 86.0K |
| Earning Date | 03-17-2026 | 03-26-2026 |
| Dividend Yield | N/A | ★ 12.21% |
| EPS Growth | N/A | ★ 50.48 |
| EPS | N/A | ★ 4.56 |
| Revenue | $21,094,000.00 | ★ $918,148,810.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $66.20 | N/A |
| P/E Ratio | ★ N/A | $1.44 |
| Revenue Growth | 3.36 | ★ 8.99 |
| 52 Week Low | $1.22 | $5.73 |
| 52 Week High | $4.02 | $19.23 |
| Indicator | OABI | JFIN |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 45.91 |
| Support Level | $1.67 | $5.81 |
| Resistance Level | $1.86 | $7.20 |
| Average True Range (ATR) | 0.11 | 0.37 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 43.01 | 49.64 |
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.